Detalles de la búsqueda
1.
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London.
Lancet
; 402(10395): 21-24, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37348521
2.
Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
Lancet
; 399(10328): 905-907, 2022 03 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35090602
3.
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
PLoS One
; 19(3): e0294897, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38512960
4.
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer.
Cancer Cell
; 41(5): 821-823, 2023 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37116490
5.
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer.
Cell Rep Med
; 3(10): 100781, 2022 10 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36240755
6.
SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay.
Wellcome Open Res
; 6: 9, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34095506
7.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.
Nat Cancer
; 2: 1321-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34950880
8.
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Res Sq
; 2021 Sep 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-34580668
9.
Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1321-1337, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121900
10.
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.
Nat Cancer
; 2(12): 1305-1320, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35121899
11.
Author Correction: Scalable and robust SARS-CoV-2 testing in an academic center.
Nat Biotechnol
; 38(8): 1000, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32681136
12.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(4): 438, 2022 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35413273
13.
Immune responses following third COVID-19 vaccination are reduced in patients with hematological malignancies compared to patients with solid cancer.
Cancer Cell
; 40(2): 114-116, 2022 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-34968417
14.
Scalable and robust SARS-CoV-2 testing in an academic center.
Nat Biotechnol
; 38(8): 927-931, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32555528
Resultados
1 -
14
de 14
1
Próxima >
>>